Long-Term Results After Percutaneous Low-Dose Streptokinase Treatment for Acute Arterial Thrombosis
The objective of this study was to evaluate the immediate efficacy and long-term results of a standard protocol of percutaneous, low dose, intraarterial streptokinase treatment in acute arterial thrombosis. This involved analysis of 48 consecutive patients with acute peripheral arterial thrombosis,...
Gespeichert in:
Veröffentlicht in: | Vascular and endovascular surgery 2000-05, Vol.34 (3), p.225-230 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 230 |
---|---|
container_issue | 3 |
container_start_page | 225 |
container_title | Vascular and endovascular surgery |
container_volume | 34 |
creator | Yilmaz, E. N. Vermeulen, E. G. J. van den Berg, F. G. Vahl, A. C. Rauwerda, J. A. |
description | The objective of this study was to evaluate the immediate efficacy and long-term results of a standard protocol of percutaneous, low dose, intraarterial streptokinase treatment in acute arterial thrombosis. This involved analysis of 48 consecutive patients with acute peripheral arterial thrombosis, treated with thrombolysis between October 1988 and August 1997. There were 30 men and 18 women patients, with an average age of 66.5 years. There was thrombosis of the native artery in 32, thrombosis of an aneurysm in seven, and graft occlusion in nine. After the occlusion was defined by arteriography, the low-dose streptokinase (10,000 units per hour) was continuously infused into the thrombosed segment following a bolus injection of 10,000 units. The initial success rate (defined as partial or complete lysis) was 79.6%. Additional therapy after lysis consisted of percutaneous transluminal angioplasty in 18, bypass surgery in six, anticoagulant therapy in seven, and amputation in seven owing to irreversible ischemic damage. One patient died of myocardial infarction before additional therapy. Of the 20.4% failures to fibrinolysis, two patients received bypass surgery, two surgical thrombectomy, three sympathectomy, and three had amputations. Local bleeding complications were seen in five (10%) patients. Only one patient needed surgical exploration. Allergic reaction to streptokinase was seen in five patients (10%) and fibrinolytic therapy was continued with urokinase in three. In the follow-up (1-107 months) eight patients died and three amputations were performed after a mean time of 17 months after thrombolysis owing to progression of arteriosclerosis. This resulted in a limb salvage rate of 76% after 1 year and 65% after 5 years (Kaplan-Meier).
Low-dose, local, intraarterial streptokinase therapy is an effective preliminary step in management of acute arterial thrombosis. Especially with adequate additional treatment, it is possible to achieve satisfactory long-term patency rates. |
doi_str_mv | 10.1177/153857440003400306 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_198738436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_153857440003400306</sage_id><sourcerecordid>54173204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c263t-8c2c1f96c27c74b2b4a455754375104b59c220d142d038cf320078834677ac543</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMouK7-AU_Be93JV5Mey_oJBUXruaTZdO26bdYkRfz3RtaDIF5mGHied4ZB6JzAJSFSLohgSkjOAYClwiA_QDNSMJUVhOSHaAbAaUYVE8foJIQNAGFSyBkylRvXWW39gJ9smLYx4LKL1uNH680U9WjdFHDlPrIrFyx-jt7uonvrR52m2lsdBztG3DmPy8RbXPpk93qL61fvhtaFPpyio05vgz376XP0cnNdL--y6uH2fllWmaE5i5ky1JCuyA2VRvKWtlxzIaTg6VICvBWFoRRWhNMVMGU6RgGkUoznUmqTsDm62OfuvHufbIjNxk1-TCsbUijJFGd5gugeMt6F4G3X7Hw_aP_ZEGi-f9n8_WWSFnsp6LX9lfq_8QWXjHLv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198738436</pqid></control><display><type>article</type><title>Long-Term Results After Percutaneous Low-Dose Streptokinase Treatment for Acute Arterial Thrombosis</title><source>Access via SAGE</source><source>Alma/SFX Local Collection</source><creator>Yilmaz, E. N. ; Vermeulen, E. G. J. ; van den Berg, F. G. ; Vahl, A. C. ; Rauwerda, J. A.</creator><creatorcontrib>Yilmaz, E. N. ; Vermeulen, E. G. J. ; van den Berg, F. G. ; Vahl, A. C. ; Rauwerda, J. A.</creatorcontrib><description>The objective of this study was to evaluate the immediate efficacy and long-term results of a standard protocol of percutaneous, low dose, intraarterial streptokinase treatment in acute arterial thrombosis. This involved analysis of 48 consecutive patients with acute peripheral arterial thrombosis, treated with thrombolysis between October 1988 and August 1997. There were 30 men and 18 women patients, with an average age of 66.5 years. There was thrombosis of the native artery in 32, thrombosis of an aneurysm in seven, and graft occlusion in nine. After the occlusion was defined by arteriography, the low-dose streptokinase (10,000 units per hour) was continuously infused into the thrombosed segment following a bolus injection of 10,000 units. The initial success rate (defined as partial or complete lysis) was 79.6%. Additional therapy after lysis consisted of percutaneous transluminal angioplasty in 18, bypass surgery in six, anticoagulant therapy in seven, and amputation in seven owing to irreversible ischemic damage. One patient died of myocardial infarction before additional therapy. Of the 20.4% failures to fibrinolysis, two patients received bypass surgery, two surgical thrombectomy, three sympathectomy, and three had amputations. Local bleeding complications were seen in five (10%) patients. Only one patient needed surgical exploration. Allergic reaction to streptokinase was seen in five patients (10%) and fibrinolytic therapy was continued with urokinase in three. In the follow-up (1-107 months) eight patients died and three amputations were performed after a mean time of 17 months after thrombolysis owing to progression of arteriosclerosis. This resulted in a limb salvage rate of 76% after 1 year and 65% after 5 years (Kaplan-Meier).
Low-dose, local, intraarterial streptokinase therapy is an effective preliminary step in management of acute arterial thrombosis. Especially with adequate additional treatment, it is possible to achieve satisfactory long-term patency rates.</description><identifier>ISSN: 0042-2835</identifier><identifier>ISSN: 1538-5744</identifier><identifier>EISSN: 1938-9116</identifier><identifier>DOI: 10.1177/153857440003400306</identifier><identifier>CODEN: VASUA9</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><ispartof>Vascular and endovascular surgery, 2000-05, Vol.34 (3), p.225-230</ispartof><rights>Copyright Westminster Publications, Inc. May/Jun 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c263t-8c2c1f96c27c74b2b4a455754375104b59c220d142d038cf320078834677ac543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/153857440003400306$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/153857440003400306$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids></links><search><creatorcontrib>Yilmaz, E. N.</creatorcontrib><creatorcontrib>Vermeulen, E. G. J.</creatorcontrib><creatorcontrib>van den Berg, F. G.</creatorcontrib><creatorcontrib>Vahl, A. C.</creatorcontrib><creatorcontrib>Rauwerda, J. A.</creatorcontrib><title>Long-Term Results After Percutaneous Low-Dose Streptokinase Treatment for Acute Arterial Thrombosis</title><title>Vascular and endovascular surgery</title><description>The objective of this study was to evaluate the immediate efficacy and long-term results of a standard protocol of percutaneous, low dose, intraarterial streptokinase treatment in acute arterial thrombosis. This involved analysis of 48 consecutive patients with acute peripheral arterial thrombosis, treated with thrombolysis between October 1988 and August 1997. There were 30 men and 18 women patients, with an average age of 66.5 years. There was thrombosis of the native artery in 32, thrombosis of an aneurysm in seven, and graft occlusion in nine. After the occlusion was defined by arteriography, the low-dose streptokinase (10,000 units per hour) was continuously infused into the thrombosed segment following a bolus injection of 10,000 units. The initial success rate (defined as partial or complete lysis) was 79.6%. Additional therapy after lysis consisted of percutaneous transluminal angioplasty in 18, bypass surgery in six, anticoagulant therapy in seven, and amputation in seven owing to irreversible ischemic damage. One patient died of myocardial infarction before additional therapy. Of the 20.4% failures to fibrinolysis, two patients received bypass surgery, two surgical thrombectomy, three sympathectomy, and three had amputations. Local bleeding complications were seen in five (10%) patients. Only one patient needed surgical exploration. Allergic reaction to streptokinase was seen in five patients (10%) and fibrinolytic therapy was continued with urokinase in three. In the follow-up (1-107 months) eight patients died and three amputations were performed after a mean time of 17 months after thrombolysis owing to progression of arteriosclerosis. This resulted in a limb salvage rate of 76% after 1 year and 65% after 5 years (Kaplan-Meier).
Low-dose, local, intraarterial streptokinase therapy is an effective preliminary step in management of acute arterial thrombosis. Especially with adequate additional treatment, it is possible to achieve satisfactory long-term patency rates.</description><issn>0042-2835</issn><issn>1538-5744</issn><issn>1938-9116</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kE1LxDAQhoMouK7-AU_Be93JV5Mey_oJBUXruaTZdO26bdYkRfz3RtaDIF5mGHied4ZB6JzAJSFSLohgSkjOAYClwiA_QDNSMJUVhOSHaAbAaUYVE8foJIQNAGFSyBkylRvXWW39gJ9smLYx4LKL1uNH680U9WjdFHDlPrIrFyx-jt7uonvrR52m2lsdBztG3DmPy8RbXPpk93qL61fvhtaFPpyio05vgz376XP0cnNdL--y6uH2fllWmaE5i5ky1JCuyA2VRvKWtlxzIaTg6VICvBWFoRRWhNMVMGU6RgGkUoznUmqTsDm62OfuvHufbIjNxk1-TCsbUijJFGd5gugeMt6F4G3X7Hw_aP_ZEGi-f9n8_WWSFnsp6LX9lfq_8QWXjHLv</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Yilmaz, E. N.</creator><creator>Vermeulen, E. G. J.</creator><creator>van den Berg, F. G.</creator><creator>Vahl, A. C.</creator><creator>Rauwerda, J. A.</creator><general>SAGE Publications</general><general>Westminster Publications, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20000501</creationdate><title>Long-Term Results After Percutaneous Low-Dose Streptokinase Treatment for Acute Arterial Thrombosis</title><author>Yilmaz, E. N. ; Vermeulen, E. G. J. ; van den Berg, F. G. ; Vahl, A. C. ; Rauwerda, J. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c263t-8c2c1f96c27c74b2b4a455754375104b59c220d142d038cf320078834677ac543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yilmaz, E. N.</creatorcontrib><creatorcontrib>Vermeulen, E. G. J.</creatorcontrib><creatorcontrib>van den Berg, F. G.</creatorcontrib><creatorcontrib>Vahl, A. C.</creatorcontrib><creatorcontrib>Rauwerda, J. A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Vascular and endovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yilmaz, E. N.</au><au>Vermeulen, E. G. J.</au><au>van den Berg, F. G.</au><au>Vahl, A. C.</au><au>Rauwerda, J. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Results After Percutaneous Low-Dose Streptokinase Treatment for Acute Arterial Thrombosis</atitle><jtitle>Vascular and endovascular surgery</jtitle><date>2000-05-01</date><risdate>2000</risdate><volume>34</volume><issue>3</issue><spage>225</spage><epage>230</epage><pages>225-230</pages><issn>0042-2835</issn><issn>1538-5744</issn><eissn>1938-9116</eissn><coden>VASUA9</coden><abstract>The objective of this study was to evaluate the immediate efficacy and long-term results of a standard protocol of percutaneous, low dose, intraarterial streptokinase treatment in acute arterial thrombosis. This involved analysis of 48 consecutive patients with acute peripheral arterial thrombosis, treated with thrombolysis between October 1988 and August 1997. There were 30 men and 18 women patients, with an average age of 66.5 years. There was thrombosis of the native artery in 32, thrombosis of an aneurysm in seven, and graft occlusion in nine. After the occlusion was defined by arteriography, the low-dose streptokinase (10,000 units per hour) was continuously infused into the thrombosed segment following a bolus injection of 10,000 units. The initial success rate (defined as partial or complete lysis) was 79.6%. Additional therapy after lysis consisted of percutaneous transluminal angioplasty in 18, bypass surgery in six, anticoagulant therapy in seven, and amputation in seven owing to irreversible ischemic damage. One patient died of myocardial infarction before additional therapy. Of the 20.4% failures to fibrinolysis, two patients received bypass surgery, two surgical thrombectomy, three sympathectomy, and three had amputations. Local bleeding complications were seen in five (10%) patients. Only one patient needed surgical exploration. Allergic reaction to streptokinase was seen in five patients (10%) and fibrinolytic therapy was continued with urokinase in three. In the follow-up (1-107 months) eight patients died and three amputations were performed after a mean time of 17 months after thrombolysis owing to progression of arteriosclerosis. This resulted in a limb salvage rate of 76% after 1 year and 65% after 5 years (Kaplan-Meier).
Low-dose, local, intraarterial streptokinase therapy is an effective preliminary step in management of acute arterial thrombosis. Especially with adequate additional treatment, it is possible to achieve satisfactory long-term patency rates.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><doi>10.1177/153857440003400306</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0042-2835 |
ispartof | Vascular and endovascular surgery, 2000-05, Vol.34 (3), p.225-230 |
issn | 0042-2835 1538-5744 1938-9116 |
language | eng |
recordid | cdi_proquest_journals_198738436 |
source | Access via SAGE; Alma/SFX Local Collection |
title | Long-Term Results After Percutaneous Low-Dose Streptokinase Treatment for Acute Arterial Thrombosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A11%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Results%20After%20Percutaneous%20Low-Dose%20Streptokinase%20Treatment%20for%20Acute%20Arterial%20Thrombosis&rft.jtitle=Vascular%20and%20endovascular%20surgery&rft.au=Yilmaz,%20E.%20N.&rft.date=2000-05-01&rft.volume=34&rft.issue=3&rft.spage=225&rft.epage=230&rft.pages=225-230&rft.issn=0042-2835&rft.eissn=1938-9116&rft.coden=VASUA9&rft_id=info:doi/10.1177/153857440003400306&rft_dat=%3Cproquest_cross%3E54173204%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198738436&rft_id=info:pmid/&rft_sage_id=10.1177_153857440003400306&rfr_iscdi=true |